SCHEDULE 13G

Statement of Beneficial Ownership

Aldeyra Therapeutics, Inc. Filed 2026-08-12 Acc 0001167557-26-000132

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-11-06 SCHEDULE 13G Statement of Beneficial Ownership
2026-08-12 SCHEDULE 13G Statement of Beneficial Ownership
2026-08-06 10-Q Quarterly Report

Link to a passage

External

SEC EDGAR (opens in new tab)